51³Ô¹ÏÍø

Tag - eli-lilly

 
 

ELI LILLY

A surgeon fills a syringe with Eli Lilly's Mounjaro, a tirzepatide injection drug used for treating type 2 diabetes and weight loss.
51³Ô¹ÏÍø / Science & Health / EXPLAINER
Jun 10, 2026
¡®Thinness equals beauty¡¯: Mounjaro misuse among women sparks health debate in Japan
The nation is one of the leanest in the world, making the misuse of the diabetes drug simply for weight loss that much more alarming.
A partly-used, 10 gram bag of semaglutide powder made by China-based Sinopep-Allsino Biopharmaceutical, at a compounding pharmacy in Arlington, Virginia, in December 2024.
BUSINESS / Companies
Sep 3, 2025
Chinese companies turn to generics as patents expire on weight-loss drugs
U.S. regulators have restricted the sale of cheap copies of the drugs, slowing demand for raw ingredients Chinese firms supplied over the past two years.
Shares of Eli Lilly & Co. surged on the New York Stock Exchange on Thursday after early reports of its experimental weight-loss drug put in a par with market leader Ozempic. The stocks of the drug¡¯s originator, Chugai Pharmaceutical Co., also saw an uptick.
BUSINESS / Companies
Apr 18, 2025
Weight-loss pill orforglipron shines in study, boosting Lilly and Chugai
Eli Lilly¡¯s orforglipron pill, licensed from Chugai Pharmaceutical, could reshape the booming weight-loss drug market, early data shows.
A scientist looks at brain scans of a patient suffering from Alzheimer's disease in Geneva in 2023.
WORLD / Science & Health
Sep 21, 2024
Revolution or mirage? Controversy surrounds new Alzheimer¡¯s drugs
For defenders, the drugs represent a real chance to fight the disease. For detractors, they are a disappointment after a long line of costly failures.
A health ministry panel has approved Eli Lilly's donanemab drug for Alzheimer's patients.
51³Ô¹ÏÍø / Science & Health
Aug 2, 2024
Japan¡¯s health ministry set to approve second Alzheimer¡¯s drug
Donanemab, developed by U.S. pharmaceutical firm Eli Lilly, has been backed by a ministry panel.
Alphabet CFO Ruth Porat
BUSINESS / Companies
Jun 6, 2024
Alphabet taps Eli Lilly executive as new CFO replacing Porat
Anat Ashkenazi will replace Ruth Porat who announced last year she planned to step down.
Japan Times
COMMENTARY / World
Jun 28, 2023
Eli Lilly¡¯s new weight-loss drug is even better than Ozempic
When it comes to manipulating the human metabolism, we¡¯re entering entirely new territory with new drugs.
Japan Times
BUSINESS
Jun 1, 2023
Obesity and Alzheimer¡¯s news makes Eli Lilly world¡¯s most valuable drugmaker
An 8.5% gain in May for Eli Lilly lifted its shares to a record high, while displaced Johnson & Johnson slumped 5.3% during the month.
Japan Times
WORLD / Science & Health
May 5, 2023
Experimental Alzheimer¡¯s drug slowed disease by 35% in trial, Eli Lilly reports
The results provide what experts say is the strongest evidence yet that removing sticky amyloid plaques from the brain benefits patients with the fatal disease.
Japan Times
WORLD / Science & Health
Nov 29, 2020
COVID-19 drugs from Lilly and Regeneron raise access and timing concerns
Powerful drugs recently authorized by the U.S. that may prevent those at the earliest stages of COVID-19 from suffering severe disease present thorny new challenges, including who will get them and where they¡¯ll be administered.
Japan Times
BUSINESS / Companies
Jan 8, 2019
Eli Lilly makes $8 billion bet on drugs for rare cancers with Loxo Oncology buy
Eli Lilly said on Monday it will buy Loxo Oncology Inc. for $8 billion, an expensive bet on a pipeline of cancer drugs that target rare genetic mutations and the biggest acquisition in the drug-maker¡¯s 143-year history.
Japan Times
51³Ô¹ÏÍø / Crime & Legal
Apr 2, 2015
Drugmaker Takeda may settle Actos suits for $2.2 billion
Officials at Asia¡¯s largest drugmaker have proposed to settle more than 8,000 lawsuits in federal and state courts in the United States, according to sources who asked to remain anonymous.

Longform

For many people, utility poles and power lines have become such a familiar part of Japan¡¯s landscape that they often go unnoticed.
Why Japan¡¯s utility poles won¡¯t be disappearing anytime soon

SUSTAINABLE 51³Ô¹ÏÍø